Advertisement
Screener

CABALETTA BIO, INC. (CABA) Shares Issued

2.8 / 5 stars · 68/120 Roast Me

CABALETTA BIO, INC. Shares Issued

CABALETTA BIO, INC. (CABA) had Shares Issued of 100.48 million shares as of 2025-12-31, per its 10-K filed 2026-03-23.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesIssued · last filed 2026-03-23

  • 2025-12-31: Common Stock, Shares, Issued 100.48M shares.
  • 2025-09-30: Common Stock, Shares, Issued 96.27M shares.
  • 2025-06-30: Common Stock, Shares, Issued 91.45M shares.
  • 2024-12-31: Common Stock, Shares, Issued 50.74M shares.
Period endCommon Stock, Shares, Issued
2025-12-31100.48M shares
10-K · filed 2026-03-23
2025-09-3096.27M shares
10-Q · filed 2025-11-10
2025-06-3091.45M shares
10-Q · filed 2025-08-07
2024-12-3150.74M shares
10-K · filed 2026-03-23
2024-09-3048.85M shares
10-Q · filed 2024-11-14
2024-06-3048.29M shares
10-Q · filed 2024-08-08
2024-03-3148.25M shares
10-Q · filed 2024-05-15
2023-12-3147.82M shares
10-K · filed 2025-03-31
2023-09-3041.66M shares
10-Q · filed 2023-11-09
2023-06-3039.79M shares
10-Q · filed 2023-08-10
2023-03-3131.34M shares
10-Q · filed 2023-05-11
2022-12-3129.45M shares
10-K · filed 2024-03-21
2022-09-3029.01M shares
10-Q · filed 2022-11-10
2022-06-3029.01M shares
10-Q · filed 2022-08-11
2022-03-3128.98M shares
10-Q · filed 2022-05-12
2021-12-3128.93M shares
10-K · filed 2023-03-16
2021-09-3027.73M shares
10-Q · filed 2021-11-01
2021-06-3024.97M shares
10-Q · filed 2021-08-05
2021-03-3124.26M shares
10-Q · filed 2021-05-03
2020-12-3124.06M shares
10-K · filed 2022-03-17
2020-09-3024.06M shares
10-Q · filed 2020-11-10
2020-06-3024.03M shares
10-Q · filed 2020-08-06
2020-03-3124.03M shares
10-Q · filed 2020-05-12
2019-12-3124.03M shares
10-K · filed 2021-03-16
2019-09-303.85M shares
10-Q · filed 2019-12-05
2018-12-313.85M shares
10-K · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
AGENUS INC (AGEN)United States$0.383B1.41
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02